A

Athos Therapeutics Inc

16 employees

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Investor insights

Sectors invested in

tissue repair1
Health Care1
Biotechnology1
Medical Device1
wound healing1
venous ulcers1
pressure ulcer1
chronic ulcers1
wound care1
diabetic foot ulcers1
burns1
wound dressing1

Funding rounds participated in

$26M sweet spot round size

Most of their 1 investments are in rounds between $26M and $26M

Basic info

Industry

biotechnology research

Sectors

autoimmune diseases
Biotechnology
chronic inflammatory diseases
Crohn's Disease
Artificial Intelligence
drug development
Medical
ulcerative colitis
machine learning
artificial intelligence
Life Science

Date founded

2019

Investments made

R

RedDress Ltd. raised $26M on May 24, 2023

Investors: HCS Capital, Ragnar Crossover Fund and Athos Therapeutics Inc

FAQ